- Home
- APLT vs OPAD Comparison
APLT vs OPAD Comparison
Compare APLT & OPAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- OPAD
- Stock Information
- Founded
- APLT 2016
- OPAD 2015
- Country
- APLT United States
- OPAD United States
- Employees
- APLT N/A
- OPAD N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- OPAD Real Estate
- Sector
- APLT Health Care
- OPAD Finance
- Exchange
- APLT Nasdaq
- OPAD Nasdaq
- Market Cap
- APLT 140.8M
- OPAD 117.4M
- IPO Year
- APLT 2019
- OPAD N/A
- Fundamental
- Price
- APLT $1.10
- OPAD $3.47
- Analyst Decision
- APLT Buy
- OPAD Hold
- Analyst Count
- APLT 6
- OPAD 6
- Target Price
- APLT $6.60
- OPAD $5.19
- AVG Volume (30 Days)
- APLT 10.8M
- OPAD 44.1K
- Earning Date
- APLT 11-07-2024
- OPAD 11-04-2024
- Dividend Yield
- APLT N/A
- OPAD N/A
- EPS Growth
- APLT N/A
- OPAD N/A
- EPS
- APLT N/A
- OPAD N/A
- Revenue
- APLT N/A
- OPAD $985,005,000.00
- Revenue This Year
- APLT N/A
- OPAD N/A
- Revenue Next Year
- APLT $5,117.00
- OPAD $37.39
- P/E Ratio
- APLT N/A
- OPAD N/A
- Revenue Growth
- APLT N/A
- OPAD N/A
- 52 Week Low
- APLT $1.03
- OPAD $2.57
- 52 Week High
- APLT $10.62
- OPAD $10.89
- Technical
- Relative Strength Index (RSI)
- APLT 17.64
- OPAD 41.16
- Support Level
- APLT $1.03
- OPAD $3.73
- Resistance Level
- APLT $1.37
- OPAD $5.13
- Average True Range (ATR)
- APLT 0.33
- OPAD 0.45
- MACD
- APLT -0.15
- OPAD -0.13
- Stochastic Oscillator
- APLT 0.75
- OPAD 10.22
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About OPAD Offerpad Solutions Inc.
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.